BOSTON and ATHENS, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced that...
Aruna BIO Establishes Stroke Advisory Board
Aruna Bio Announces FDA Clearance of IND for Lead Program AB126
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory and neuroprotective properties through modulation of the ATP-adenosine axis – ...
- Data from superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) mouse model demonstrated prolonged survival and reduced inflammation in the spinal cord “ -AB126, an unmodified exosome...
- Preclinical data demonstrates AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity and evidence of anti-inflammatory and neuroprotective properties “ -...
BOSTON and ATHENS, Ga., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors
BOSTON and ATHENS, Ga., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced an oral presentation at the Exosome Based Therapeutic Development Summit, being held in Boston, MA from October 4-6, 2022. The presentation featured proof-of-concept data that highlight the neural exosome treatment opportunities and support the advancement of Aruna’s lead program, AB126, an unmodified neural-derived exosome with the innate ability to cross the blood-brain barrier. AB126 is designed to provide potential therapeutic benefit in its native form for multiple different neurological indications.